BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)
$2.14 -0.04 (-1.8349%)
Analysed BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) News Sources
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
10-11-2025
yahoo.com
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
29-12-2025
yahoo.com
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
27-01-2026
yahoo.com
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
17-02-2026
yahoo.com
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
20-02-2026
yahoo.com
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
06-03-2026
yahoo.com
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics
11-03-2026
yahoo.com
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
12-03-2026
yahoo.com
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
07-04-2026
yahoo.com
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
07-05-2026
yahoo.com
What is the current price of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The current price of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is $2.14.
BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) since the previous trading day is $-0.04.
BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) since the previous trading day is -1.8349%.
What is the most recent average sentiment score for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The most recent average sentiment score for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)?
The most recent sentiment for BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ) is .
SEC-8K** Filing Available For BLUEJAY DIAGNOSTICS INC (BJDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.